Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Red Violet, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-85.3% vs price
Base Case (Median)
-75.3% vs price
Bull Case (75th pct.)
-47.1% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $7.70 | -89.3% | High (40%) |
| PE Comparable | $28.79 | -60.0% | Medium (25%) |
| Growth Trajectory DCF | $61.53 | -14.5% | Medium (20%) |
| Graham Number | $13.45 | -81.3% | Low (10%) |
| EV/EBITDA | $17.80 | -75.3% | Medium (20%) |
| EV/FCF | $47.41 | -34.1% | Medium (20%) |
| Earnings Power Value | $6.22 | -91.4% | Medium (50%) |
Based on 7 out of 8 methods, RDVT appears overvalued at the current price of $72.00. The base case fair value of $17.80 implies 75.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.
